The United States Patent & Trademark office (USPTO) is running a study on patent eligibility jurisprudence in the United States, and how the current jurisprudence has impacted investment and innovation.[1] The USPTO is particularly interested in the impact on the following technologies: quantum computing, artificial intelligence, precision medicine, diagnostic methods, and pharmaceutical treatments.

The USPTO is accepting comments until September 7, 2021. All comments must be submitted through the Federal eRulemaking Portal at and all comments will be made available for public inspection.[2]